4//SEC Filing
Tokman Alexander Y 4
Accession 0001209191-21-002827
CIK 0001681682other
Filed
Jan 7, 7:00 PM ET
Accepted
Jan 8, 7:10 PM ET
Size
4.9 KB
Accession
0001209191-21-002827
Insider Transaction Report
Form 4
Tokman Alexander Y
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2021-01-08$0.90/sh−10,000$9,000→ 32,857 total
Footnotes (1)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan in order to pay the tax liability associated with the vesting of restricted stock units which were granted to the Reporting Person on April 9, 2020.
Documents
Issuer
ENDRA Life Sciences Inc.
CIK 0001681682
Entity typeother
Related Parties
1- filerCIK 0001334483
Filing Metadata
- Form type
- 4
- Filed
- Jan 7, 7:00 PM ET
- Accepted
- Jan 8, 7:10 PM ET
- Size
- 4.9 KB